Log In
BCIQ
Print this Print this
 

Yasmin

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionOral contraceptive contains drospirenone and ethinyl estradiol
Molecular Target Progesterone receptor (PGR) ; Estrogen receptor 1 (ESR1)
Mechanism of ActionMineralocorticoid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationContraception
Indication DetailsPrevent conception
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/28/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today